ENVB – enveric biosciences, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ENVB

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/2

08:19 am

envb

Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds [Yahoo! Finance]

Medium Report

Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds [Yahoo! Finance]

Report

12/2

08:00 am

envb

Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds

High Report

Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds

Report

11/25

09:06 am

envb

Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior [Yahoo! Finance]

High Report

Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior [Yahoo! Finance]

Report

11/25

09:00 am

envb

Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior

High Report

Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior

Report

11/14

04:09 pm

envb

Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results [Yahoo! Finance]

High Report

Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results [Yahoo! Finance]

Report

11/14

04:05 pm

envb

Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results

Medium Report

Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results

Report

11/12

09:00 am

envb

Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002

High Report

Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002

Report

11/4

09:00 am

envb

Enveric Biosciences Announces Broad Range of Patent Issuances

Medium Report

Enveric Biosciences Announces Broad Range of Patent Issuances

Report

10/15

08:00 am

envb

Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003

High Report

Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.